OLMA 241220 10.00C (OLMA241220C10000) Stock Options, News & Quotes

US OptionsDetailed Quotes

OLMA241220C10000

Watchlist

1.00
-0.95-48.72%

15min DelayClose Nov 27 16:00 ET

1.00High1.00Low

Intraday

5D
Daily

News

Citi Remains a Buy on Olema Pharmaceuticals (OLMA)
TipRanksNov 28 06:15 ET · Ratings
(SEC Amendment) Olema Pharmaceuticals(OLMA.US) Director Sells US$17.45 Million in Common Stock
Moomoo NewsNov 26 16:59 ET
Olema Oncology to Present New Data Combining Palazestrant With Ribociclib at the San Antonio Breast Cancer Symposium
GlobeNewswireNov 25 17:30 ET
J.P. Morgan Keeps Their Buy Rating on Olema Pharmaceuticals (OLMA)
TipRanksNov 21 07:11 ET · Ratings
Express News | Olema Pharmaceuticals Inc : JP Morgan Cuts Target Price to $29 From $31
ReutersNov 20 00:36 ET
A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $29 to $30
Moomoo NewsNov 14 08:00 ET · Ratings

Comments

Moomoo AI

Nov 25, 2023 06:49

Although the sale doesn't necessarily signify a negative view on the company's future, absence of insider buying could induce concerns. Other company risks should be considered when investing.

President Sean Bohen Sold A Bunch Of Shares In Olema Pharmaceuticals

Moomoo AI

Oct 17, 2023 06:06

Mr. Garland's expertise in biopharma is predicted to boost late-stage development of Olema's lead product. This could solidify the company's influence in shaping next-gen therapies for women's cancers.

Press Release: Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors

Weight-loss drugmakers report strong earnings: Boon or bane?

Trytosaveabit

Oct 12, 2023 06:17

NEWS!

$Olema Pharmaceuticals (OLMA.US)$ Olema Pharmaceuticals Announced New Preclinical Data Regarding The Discovery Of Novel Compounds Targeting KAT6, An Epigenetic Target That Is Dysregulated In Breast And Other Cancers

Rivera

May 17, 2023 09:29

Caming

$Olema Pharmaceuticals (OLMA.US)$

Alvinnnnnnngenius

Feb 22, 2023 08:36

Halt up

$Olema Pharmaceuticals (OLMA.US)$